Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.

Jeremy Slivnick,Matthew S. Tong,Haikady N. Nagaraja,Mohamed B. Elamin,Alex Wallner,aaron o'brien,Subha V. Raman,Karolina M. Zareba

Novel Cardiovascular Magnetic Resonance Model to Distinguish Immunoglobulin Light Chain From Transthyretin Cardiac Amyloidosis.

2020

Jeremy Slivnick
Matthew S. Tong
Haikady N. Nagaraja
Mohamed B. Elamin
Alex Wallner
aaron o'brien
Subha V. Raman
Karolina M. Zareba

Myocardial deposition of transthyretin (ATTR) or immunoglobulin light chain (AL) underlies cardiac amyloidosis (CA), with distinct treatments for each requiring accurate diagnosis. Cardiovascular magnetic resonance (CMR) is a valuable diagnostic and prognostic tool for CA ([1][1]). We report a novel

Keywords:

Cardiac amyloidosis
Transthyretin
Pathology
Immunoglobulin light chain
Magnetic resonance imaging
Medicine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations